Please enable JavaScript to continue using this application.

Compare $ANIX vs $CRBP | Chartloom

Compare

$ANIX vs $CRBP

Anixa Biosciences Inc · Corbus Pharmaceuticals Holdings Inc

ANIX

Anixa Biosciences Inc

CRBP

Corbus Pharmaceuticals Holdings Inc

Compare $ANIX vs $CRBP

Comparing Anixa Biosciences Inc and Corbus Pharmaceuticals Holdings Inc

ANIXAnixa Biosciences Inc

CRBPCorbus Pharmaceuticals Holdings Inc

ANIXAnixa Biosciences Inc

Market cap

$99M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-8.2%

52W performance

-34.7%

FCF yield

-7.5%

CRBPCorbus Pharmaceuticals Holdings Inc

Market cap

$100M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-31.6%

52W performance

-59.9%

FCF yield

-87.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ANIX

CRBP

Detailed metrics comparison

ANIX

Anixa Biosciences Inc

CRBP

Corbus Pharmaceuticals Holdings Inc

Market Cap

ANIX$99M

CRBP$100M

Enterprise Value

ANIX$97M

CRBP$76M

Price

ANIX$2.90

CRBP$5.38

P/E Ratio

ANIXN/A

CRBPN/A

P/S Ratio

ANIX488.35x

CRBP76.49x

EV/Sales

ANIX481.69x

CRBP61.41x

EV/EBITDA

ANIX0.00x

CRBP0.00x

P/B Ratio

ANIX7.09x

CRBP1.16x

P/FCF Ratio

ANIXN/A

CRBPN/A

EV/FCF

ANIX-13.19x

CRBP-0.88x

PEG Ratio

ANIXN/A

CRBPN/A

Forward P/E (NTM)

ANIXN/A

CRBPN/A

Forward P/S (NTM)

ANIXN/A

CRBPN/A

Revenue (TTM)

ANIX$0

CRBP$0

Revenue Growth (YoY)

ANIXN/A

CRBPN/A

Forward Rev Growth

ANIX139.6%

CRBP116.0%

Gross Margin (TTM)

ANIX100.0%

CRBP0.0%

Operating Margin (TTM)

ANIX0.0%

CRBP0.0%

EBITDA Margin (TTM)

ANIX0.0%

CRBP0.0%

Net Margin (TTM)

ANIX0.0%

CRBP0.0%

FCF Margin (TTM)

ANIXN/A

CRBPN/A

Net Income (TTM)

ANIX$-10M

CRBP$-102M

FCF (TTM)

ANIX$-7M

CRBP$-87M

EPS (TTM)

ANIX-$0.30

CRBP-$5.25

ROE (TTM)

ANIX-7017.0%

CRBP-8705.0%

ROA (TTM)

ANIX-6780.0%

CRBP-7422.0%

ROIC (TTM)

ANIX-7017.0%

CRBP-8705.0%

Cash

ANIX$1M

CRBP$23M

Debt

ANIX$0

CRBP$0

Net Cash/Debt

ANIX$1M

CRBP$23M

Current Ratio (TTM)

ANIX8.55x

CRBP5.71x

Quick Ratio (TTM)

ANIX7.95x

CRBP5.62x

Debt/Equity (TTM)

ANIX0.00x

CRBP0.00x

Debt/Assets (TTM)

ANIX0.0%

CRBP0.0%

Interest Coverage (TTM)

ANIXN/A

CRBPN/A

Net Debt/EBITDA (TTM)

ANIX0.00x

CRBP0.00x

Beta

ANIX0.47

CRBP2.74

52W Performance

ANIX-34.7%

CRBP-59.9%

YTD Performance

ANIX-8.2%

CRBP-31.6%

% from 52W High

ANIX-46.9%

CRBP-73.8%

% from 52W Low

ANIX25.0%

CRBP4.9%

Asset Turnover (TTM)

ANIX0.01x

CRBP0.01x

FCF Yield (TTM)

ANIX-7.5%

CRBP-87.0%

Earnings Yield (TTM)

ANIX-10.5%

CRBP-102.2%

Dividend Yield (TTM)

ANIXN/A

CRBPN/A

Rule of 40

ANIX0.0

CRBP0.0

EV/GP/RG

ANIXN/A

CRBPN/A

Ticker research

View ANIX research View CRBP research

Metric	ANIX Anixa Biosciences Inc	CRBP Corbus Pharmaceuticals Holdings Inc
Market & Valuation
Market Cap	$99M	$100M
Enterprise Value	$97M	$76M
Price	$2.90	$5.38
P/E Ratio	N/A	N/A
P/S Ratio	488.35x	76.49x
EV/Sales	481.69x	61.41x
EV/EBITDA	0.00x	0.00x
P/B Ratio	7.09x	1.16x
P/FCF Ratio	N/A	N/A
EV/FCF	-13.19x	-0.88x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	139.6%	116.0%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-10M	$-102M
FCF (TTM)	$-7M	$-87M
EPS (TTM)	-$0.30	-$5.25
ROE (TTM)	-7017.0%	-8705.0%
ROA (TTM)	-6780.0%	-7422.0%
ROIC (TTM)	-7017.0%	-8705.0%
Financial Health
Cash	$1M	$23M
Debt	$0	$0
Net Cash/Debt	$1M	$23M
Current Ratio (TTM)	8.55x	5.71x
Quick Ratio (TTM)	7.95x	5.62x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.47	2.74
52W Performance	-34.7%	-59.9%
YTD Performance	-8.2%	-31.6%
% from 52W High	-46.9%	-73.8%
% from 52W Low	25.0%	4.9%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.01x
FCF Yield (TTM)	-7.5%	-87.0%
Earnings Yield (TTM)	-10.5%	-102.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ANIX research	View CRBP research

Valuation

P/S Ratio

CRBP

76.49x

ANIX

488.35x

EV/FCF

ANIX

-13.19x

CRBP

-0.88x

Growth & revenue

Forward Revenue Growth

ANIX

139.6%

CRBP

116.0%

Profitability & performance

Gross Margin

ANIX

100.0%

CRBP

0.0%

ROE

ANIX

-7017.0%

CRBP

-8705.0%

FCF Yield %

ANIX

-7.5%

CRBP

-87.0%

52-Week Performance

ANIX

-34.7%

CRBP

-59.9%

Detailed metrics comparison

ANIX

Anixa Biosciences Inc

CRBP

Corbus Pharmaceuticals Holdings Inc

Market Cap

ANIX$99M

CRBP$100M

Enterprise Value

ANIX$97M

CRBP$76M

Price

ANIX$2.90

CRBP$5.38

P/E Ratio

ANIXN/A

CRBPN/A

P/S Ratio

ANIX488.35x

CRBP76.49x

EV/Sales

ANIX481.69x

CRBP61.41x

EV/EBITDA

ANIX0.00x

CRBP0.00x

P/B Ratio

ANIX7.09x

CRBP1.16x

P/FCF Ratio

ANIXN/A

CRBPN/A

EV/FCF

ANIX-13.19x

CRBP-0.88x

PEG Ratio

ANIXN/A

CRBPN/A

Forward P/E (NTM)

ANIXN/A

CRBPN/A

Forward P/S (NTM)

ANIXN/A

CRBPN/A

Revenue (TTM)

ANIX$0

CRBP$0

Revenue Growth (YoY)

ANIXN/A

CRBPN/A

Forward Rev Growth

ANIX139.6%

CRBP116.0%

Gross Margin (TTM)

ANIX100.0%

CRBP0.0%

Operating Margin (TTM)

ANIX0.0%

CRBP0.0%

EBITDA Margin (TTM)

ANIX0.0%

CRBP0.0%

Net Margin (TTM)

ANIX0.0%

CRBP0.0%

FCF Margin (TTM)

ANIXN/A

CRBPN/A

Net Income (TTM)

ANIX$-10M

CRBP$-102M

FCF (TTM)

ANIX$-7M

CRBP$-87M

EPS (TTM)

ANIX-$0.30

CRBP-$5.25

ROE (TTM)

ANIX-7017.0%

CRBP-8705.0%

ROA (TTM)

ANIX-6780.0%

CRBP-7422.0%

ROIC (TTM)

ANIX-7017.0%

CRBP-8705.0%

Cash

ANIX$1M

CRBP$23M

Debt

ANIX$0

CRBP$0

Net Cash/Debt

ANIX$1M

CRBP$23M

Current Ratio (TTM)

ANIX8.55x

CRBP5.71x

Quick Ratio (TTM)

ANIX7.95x

CRBP5.62x

Debt/Equity (TTM)

ANIX0.00x

CRBP0.00x

Debt/Assets (TTM)

ANIX0.0%

CRBP0.0%

Interest Coverage (TTM)

ANIXN/A

CRBPN/A

Net Debt/EBITDA (TTM)

ANIX0.00x

CRBP0.00x

Beta

ANIX0.47

CRBP2.74

52W Performance

ANIX-34.7%

CRBP-59.9%

YTD Performance

ANIX-8.2%

CRBP-31.6%

% from 52W High

ANIX-46.9%

CRBP-73.8%

% from 52W Low

ANIX25.0%

CRBP4.9%

Asset Turnover (TTM)

ANIX0.01x

CRBP0.01x

FCF Yield (TTM)

ANIX-7.5%

CRBP-87.0%

Earnings Yield (TTM)

ANIX-10.5%

CRBP-102.2%

Dividend Yield (TTM)

ANIXN/A

CRBPN/A

Rule of 40

ANIX0.0

CRBP0.0

EV/GP/RG

ANIXN/A

CRBPN/A

Ticker research

View ANIX research View CRBP research

Metric	ANIX Anixa Biosciences Inc	CRBP Corbus Pharmaceuticals Holdings Inc
Market & Valuation
Market Cap	$99M	$100M
Enterprise Value	$97M	$76M
Price	$2.90	$5.38
P/E Ratio	N/A	N/A
P/S Ratio	488.35x	76.49x
EV/Sales	481.69x	61.41x
EV/EBITDA	0.00x	0.00x
P/B Ratio	7.09x	1.16x
P/FCF Ratio	N/A	N/A
EV/FCF	-13.19x	-0.88x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	139.6%	116.0%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-10M	$-102M
FCF (TTM)	$-7M	$-87M
EPS (TTM)	-$0.30	-$5.25
ROE (TTM)	-7017.0%	-8705.0%
ROA (TTM)	-6780.0%	-7422.0%
ROIC (TTM)	-7017.0%	-8705.0%
Financial Health
Cash	$1M	$23M
Debt	$0	$0
Net Cash/Debt	$1M	$23M
Current Ratio (TTM)	8.55x	5.71x
Quick Ratio (TTM)	7.95x	5.62x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.47	2.74
52W Performance	-34.7%	-59.9%
YTD Performance	-8.2%	-31.6%
% from 52W High	-46.9%	-73.8%
% from 52W Low	25.0%	4.9%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.01x
FCF Yield (TTM)	-7.5%	-87.0%
Earnings Yield (TTM)	-10.5%	-102.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ANIX research	View CRBP research